Translational Research in Pediatric and Obstetric Pharmacology R21 Federal Grant

Home

RESEARCH

ARTICLES

RESOURCES

Government Jobs
Grant Forums

FAST GRANT SEARCH

FEDERAL GRANTS NEWSLETTER

Translational Research in Pediatric and Obstetric Pharmacology (R21)

The summary for the Translational Research in Pediatric and Obstetric Pharmacology (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.

Federal Grant Title:	TRANSLATIONAL RESEARCH IN PEDIATRIC AND OBSTETRIC PHARMACOLOGY (R21)
Federal Agency Name:	National Institutes of Health
Program Name:	Child Health and Human Development Extramural Research
Grant Categories:	Health Income Security and Social Services
CFDA Number:	93.865
Funding Opportunity Number:	PAR-11-248
Posted Date:	Jul 12, 2011
Creation Date:	Jul 12, 2011
Original Application Deadline:	May 15, 2013
Current Application Deadline:	May 15, 2013
Archive Date:	Jun 15, 2013
Total Program Funding:	Information not provided
Maximum Federal Grant Award:	$275,000
Minimum Federal Grant Award:	Information not provided
Expected Number of Awards:	Information not provided
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Grant Description: The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and/or in pregnant women and the developing fetus. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/par-11-248.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agricultural...; • Male Contraceptive Development Program (U01); • Orthotics for Healthy Development (STTR) (R41); • Orthotics for Pediatric Populations (SBIR) (R43); • Specialized Cooperative Centers Program in Reproduction and Infertility Research (U54); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...; • Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health: • NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01); • Biophysical and Biomechanical Aspects of Embryonic Development (R01); • Biophysical and Biomechanical Aspects of Embryonic Development (R21); • Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agricultural...; • MARC Undergraduate Student Training in Academic Research (U-STAR) National Research Servic...